You have no items in your shopping cart.
Cart summary
Item 1 of 5
Item 1 of 5
Anti-NKG2A / CD159a Reference Antibody (monalizumab)
Catalog Number: orb1806134
| Catalog Number | orb1806134 |
|---|---|
| Category | Antibodies |
| Description | Anti-NKG2A / CD159a Reference Antibody is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa. |
| Clonality | Monoclonal |
| Tested applications | ELISA, FA, FACS, Kinetics |
| Reactivity | Human |
| Isotype | IgG |
| Purity | > 95% |
| Conjugation | Unconjugated |
| MW | 145.5 kDa |
| Target | NKG2A / CD159a |
| Endotoxins | < 1 EU/mg |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Buffer/Preservatives | 100 mM Pro-Ac 20 mM Arg pH 5.0 |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
Anti-NKG2A / CD94 Reference Antibody (monalizumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.
The purity of Anti-NKG2A / CD94 Reference Antibody (monalizumab)is more than 95% ;determined by SEC-HPLC.
Human NKG2A/CD94 HEK293 cells were stained with Anti-NKG2A / CD94 Reference Antibody (monalizumab) and negative control protein respectively; washed and then followed by PE and analyzed with FACS; EC480=0.0409 μg/mL.
Anti-NKG2A / CD159a Reference Antibody (monalizumab) FACS Blocking was evaluated using human NKG2A/CD94 HEK293 cells. The IC50 was approximately 0.2162 nM.
Anti-NKG2A / CD159a Reference Antibody (monalizumab) Luciferase Assay was evaluated using Human NKG2A/CD94 HEK293. The EC50 was approximately 0.5236 nM.
